HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

IDS 30

a stinging nettle leaf extract used to treat chronic colitis

Also Known As:

IDS-30; IDS30 extract

Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - IDS 30: 3
Pharmaceutical Preparations
- Plant Extracts: 3916
  - IDS 30: 3

Experts

1.	Biggs, Melanie M: 1 article (06/2006)
2.	Carmody, Thomas J: 1 article (06/2006)
3.	Crismon, M Lynn: 1 article (06/2006)
4.	Ibrahim, Hisham M: 1 article (06/2006)
5.	Kashner, T Michael: 1 article (06/2006)
6.	Rush, A John: 1 article (06/2006)
7.	Shores-Wilson, Kathy: 1 article (06/2006)
8.	Toprac, Marcia G: 1 article (06/2006)
9.	Trivedi, Madhukar H: 1 article (06/2006)
10.	Arni, Stephan: 1 article (01/2005)

Related Diseases

1.	Colitis 01/01/2005 - "The long-term use of IDS 30 is effective in the prevention of chronic murine colitis. " 01/01/2005 - "Mice with chronic DSS colitis or IL-10-/- mice treated with IDS 30 clinically and histologically revealed significantly (p < 0.05) fewer signs of colitis than untreated animals. " 01/01/2005 - "We investigated the effect of IDS 30 on disease activity of murine colitis in different models. " 01/01/2005 - "Ameliorative effect of IDS 30, a stinging nettle leaf extract, on chronic colitis." 01/01/2005 - "C3H.IL-10-/- and BALB/c mice with colitis induced by dextran sodium sulphate (DSS) were treated with either IDS 30 or water. "
2.	Rheumatic Diseases (Rheumatism) 04/01/2002 - "The stinging nettle leaf extract IDS 30 (Hox alpha) has been recommended for adjuvant therapy of rheumatic diseases. " 01/01/2005 - "The stinging nettle leaf extract, IDS 30, is an adjuvant remedy in rheumatic diseases dependent on a cytokine suppressive effect. "
3.	Major Depressive Disorder (Major Depressive Disorders) 06/01/2006 - "Either the IDS-30 or the QIDS-16 self-report adequately assesses depressive symptom severity among public-sector outpatients with major depressive disorder. "

Related Drugs and Biologics

1.	Cytokines
2.	Sodium
3.	Dextrans (Dextran)

Related Therapies and Procedures

1.	Therapeutics